BAHL & GAYNOR INC - Q3 2022 holdings

$15.1 Billion is the total value of BAHL & GAYNOR INC's 453 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 100.0% .

 Value Shares↓ Weighting
MBII ExitMarrone Bio Innovations Inc (m$0-10,000
-100.0%
0.00%
NVDA ExitNVIDIA Corp$0-1,420
-100.0%
-0.00%
WELL ExitWelltower Inc$0-2,480
-100.0%
-0.00%
VEA ExitVanguard Tax Mgd FTSE Dev Mkt$0-4,906
-100.0%
-0.00%
DD ExitDuPont de Nemours Inc$0-4,251
-100.0%
-0.00%
CNXC ExitConcentrix Corp$0-1,774
-100.0%
-0.00%
CDK ExitCdk Global Inc (cdk.old) Delis$0-6,498
-100.0%
-0.00%
AXP ExitAmerican Express Co$0-1,663
-100.0%
-0.00%
IIVI ExitIIVI Inc$0-41,797
-100.0%
-0.01%
PETS ExitPetMed Express Inc$0-113,861
-100.0%
-0.02%
IIPR ExitInnovative Industrial Properti$0-36,008
-100.0%
-0.03%
MANT ExitManTech Intl Corp Cl A$0-63,940
-100.0%
-0.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corporation42Q3 20235.2%
Procter & Gamble Co.42Q3 20236.1%
NextEra Energy, Inc.42Q3 20237.5%
Home Depot Inc.42Q3 20233.9%
JPMorgan Chase & Co42Q3 20234.1%
PepsiCo, Inc.42Q3 20233.3%
Cisco Systems Inc.42Q3 20233.8%
AbbVie Inc.42Q3 20233.5%
Johnson & Johnson42Q3 20233.3%
Texas Instruments, Inc.42Q3 20233.5%

View BAHL & GAYNOR INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-10
13F-HR2024-02-02
13F-HR2023-11-03
13F-HR2023-08-14
13F-HR2023-05-03
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-08
13F-HR2022-05-12
13F-HR2022-02-10

View BAHL & GAYNOR INC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (15093108000.0 != 15093109000.0)

Export BAHL & GAYNOR INC's holdings